aluates Reports

$ 0.0

Automative

Global Long-acting Melatonin Receptor Agonists Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-0E19413

BUY CHAPTERS

Global Long-acting Melatonin Receptor Agonists Market Research Report 2025

Code: QYRE-Auto-0E19413

Report

February 2025

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Vanda Pharmaceuticals

Servier Laboratories

Rovi Pharma

Novartis

Nectid Inc

Takeda

Dr. Reddy’s Laboratories

Jiangsu Hausen Pharmaceuticals

Guangdong Annuo Pharmaceuticals

Sichuan Kelun Pharmaceuticals

Hangzhou Lingye Pharmaceutical Technology

Sichuan Guowei Pharmaceuticals

Long-acting Melatonin Receptor Agonists Market Size

The global market for Long-acting Melatonin Receptor Agonists was valued at US$ 1069 million in the year 2024 and is projected to reach a revised size of US$ 2469 million by 2031, growing at a CAGR of 11.5% during the forecast period.

Long-acting Melatonin Receptor Agonists Market

Melatonin receptor agonists are a class of drugs that work by binding to melatonin receptors. Melatonin is a hormone secreted by the pineal gland that plays a key role in regulating the sleep-wake cycle. Melatonin receptor agonists mimic the effects of melatonin, promoting sleep, and are commonly used to treat insomnia, circadian rhythm disorders, and other sleep disturbances. These drugs generally have fewer side effects and are considered safer than traditional sedative-hypnotics.

North American market for Long-acting Melatonin Receptor Agonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Long-acting Melatonin Receptor Agonists is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Long-acting Melatonin Receptor Agonists in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Long-acting Melatonin Receptor Agonists include Vanda Pharmaceuticals, Servier Laboratories, Rovi Pharma, Novartis, Nectid Inc, Jiangsu Hausen Pharmaceuticals, Guangdong Annuo Pharmaceuticals, Sichuan Kelun Pharmaceuticals, Hangzhou Lingye Pharmaceutical Technology, Sichuan Guowei Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Long-acting Melatonin Receptor Agonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting Melatonin Receptor Agonists.

The Long-acting Melatonin Receptor Agonists market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Long-acting Melatonin Receptor Agonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Long-acting Melatonin Receptor Agonists companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Long-acting Melatonin Receptor Agonists Market Report

Report Metric	Details
Report Name	Long-acting Melatonin Receptor Agonists Market
Accounted market size in year	US$ 1069 million
Forecasted market size in 2031	US$ 2469 million
CAGR	11.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Ramelteon Agomelatine Other
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Vanda Pharmaceuticals, Servier Laboratories, Rovi Pharma, Novartis, Nectid Inc, Jiangsu Hausen Pharmaceuticals, Guangdong Annuo Pharmaceuticals, Sichuan Kelun Pharmaceuticals, Hangzhou Lingye Pharmaceutical Technology, Sichuan Guowei Pharmaceuticals, Takeda, Dr Reddy's Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Long-acting Melatonin Receptor Agonists company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Long-acting Melatonin Receptor Agonists Market growing?

Ans: The Long-acting Melatonin Receptor Agonists Market witnessing a CAGR of 11.5% during the forecast period 2025-2031.

What is the Long-acting Melatonin Receptor Agonists Market size in 2031?

Ans: The Long-acting Melatonin Receptor Agonists Market size in 2031 will be US$ 2469 million.

Who are the main players in the Long-acting Melatonin Receptor Agonists Market report?

Ans: The main players in the Long-acting Melatonin Receptor Agonists Market are Vanda Pharmaceuticals, Servier Laboratories, Rovi Pharma, Novartis, Nectid Inc, Jiangsu Hausen Pharmaceuticals, Guangdong Annuo Pharmaceuticals, Sichuan Kelun Pharmaceuticals, Hangzhou Lingye Pharmaceutical Technology, Sichuan Guowei Pharmaceuticals, Takeda, Dr Reddy's Laboratories

What are the Application segmentation covered in the Long-acting Melatonin Receptor Agonists Market report?

Ans: The Applications covered in the Long-acting Melatonin Receptor Agonists Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Long-acting Melatonin Receptor Agonists Market report?

Ans: The Types covered in the Long-acting Melatonin Receptor Agonists Market report are Ramelteon, Agomelatine, Other

Recommended Reports

Sleep Disorder Therapeutics

Receptor Agonist Markets

Melatonin & Sleep Aids

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Long-acting Melatonin Receptor Agonists Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Ramelteon

1.2.3 Agomelatine

1.2.4 Other

1.3 Market by Application

1.3.1 Global Long-acting Melatonin Receptor Agonists Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Long-acting Melatonin Receptor Agonists Market Perspective (2020-2031)

2.2 Global Long-acting Melatonin Receptor Agonists Growth Trends by Region

2.2.1 Global Long-acting Melatonin Receptor Agonists Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Long-acting Melatonin Receptor Agonists Historic Market Size by Region (2020-2025)

2.2.3 Long-acting Melatonin Receptor Agonists Forecasted Market Size by Region (2026-2031)

2.3 Long-acting Melatonin Receptor Agonists Market Dynamics

2.3.1 Long-acting Melatonin Receptor Agonists Industry Trends

2.3.2 Long-acting Melatonin Receptor Agonists Market Drivers

2.3.3 Long-acting Melatonin Receptor Agonists Market Challenges

2.3.4 Long-acting Melatonin Receptor Agonists Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Long-acting Melatonin Receptor Agonists Players by Revenue

3.1.1 Global Top Long-acting Melatonin Receptor Agonists Players by Revenue (2020-2025)

3.1.2 Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Players (2020-2025)

3.2 Global Top Long-acting Melatonin Receptor Agonists Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Long-acting Melatonin Receptor Agonists Revenue

3.4 Global Long-acting Melatonin Receptor Agonists Market Concentration Ratio

3.4.1 Global Long-acting Melatonin Receptor Agonists Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Long-acting Melatonin Receptor Agonists Revenue in 2024

3.5 Global Key Players of Long-acting Melatonin Receptor Agonists Head office and Area Served

3.6 Global Key Players of Long-acting Melatonin Receptor Agonists, Product and Application

3.7 Global Key Players of Long-acting Melatonin Receptor Agonists, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Long-acting Melatonin Receptor Agonists Breakdown Data by Type

4.1 Global Long-acting Melatonin Receptor Agonists Historic Market Size by Type (2020-2025)

4.2 Global Long-acting Melatonin Receptor Agonists Forecasted Market Size by Type (2026-2031)

5 Long-acting Melatonin Receptor Agonists Breakdown Data by Application

5.1 Global Long-acting Melatonin Receptor Agonists Historic Market Size by Application (2020-2025)

5.2 Global Long-acting Melatonin Receptor Agonists Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Long-acting Melatonin Receptor Agonists Market Size (2020-2031)

6.2 North America Long-acting Melatonin Receptor Agonists Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Long-acting Melatonin Receptor Agonists Market Size by Country (2020-2025)

6.4 North America Long-acting Melatonin Receptor Agonists Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Long-acting Melatonin Receptor Agonists Market Size (2020-2031)

7.2 Europe Long-acting Melatonin Receptor Agonists Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2020-2025)

7.4 Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size (2020-2031)

8.2 Asia-Pacific Long-acting Melatonin Receptor Agonists Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size by Region (2020-2025)

8.4 Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Long-acting Melatonin Receptor Agonists Market Size (2020-2031)

9.2 Latin America Long-acting Melatonin Receptor Agonists Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Long-acting Melatonin Receptor Agonists Market Size by Country (2020-2025)

9.4 Latin America Long-acting Melatonin Receptor Agonists Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size (2020-2031)

10.2 Middle East & Africa Long-acting Melatonin Receptor Agonists Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Country (2020-2025)

10.4 Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Vanda Pharmaceuticals

11.1.1 Vanda Pharmaceuticals Company Details

11.1.2 Vanda Pharmaceuticals Business Overview

11.1.3 Vanda Pharmaceuticals Long-acting Melatonin Receptor Agonists Introduction

11.1.4 Vanda Pharmaceuticals Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025)

11.1.5 Vanda Pharmaceuticals Recent Development

11.2 Servier Laboratories

11.2.1 Servier Laboratories Company Details

11.2.2 Servier Laboratories Business Overview

11.2.3 Servier Laboratories Long-acting Melatonin Receptor Agonists Introduction

11.2.4 Servier Laboratories Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025)

11.2.5 Servier Laboratories Recent Development

11.3 Rovi Pharma

11.3.1 Rovi Pharma Company Details

11.3.2 Rovi Pharma Business Overview

11.3.3 Rovi Pharma Long-acting Melatonin Receptor Agonists Introduction

11.3.4 Rovi Pharma Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025)

11.3.5 Rovi Pharma Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Long-acting Melatonin Receptor Agonists Introduction

11.4.4 Novartis Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 Nectid Inc

11.5.1 Nectid Inc Company Details

11.5.2 Nectid Inc Business Overview

11.5.3 Nectid Inc Long-acting Melatonin Receptor Agonists Introduction

11.5.4 Nectid Inc Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025)

11.5.5 Nectid Inc Recent Development

11.6 Jiangsu Hausen Pharmaceuticals

11.6.1 Jiangsu Hausen Pharmaceuticals Company Details

11.6.2 Jiangsu Hausen Pharmaceuticals Business Overview

11.6.3 Jiangsu Hausen Pharmaceuticals Long-acting Melatonin Receptor Agonists Introduction

11.6.4 Jiangsu Hausen Pharmaceuticals Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025)

11.6.5 Jiangsu Hausen Pharmaceuticals Recent Development

11.7 Guangdong Annuo Pharmaceuticals

11.7.1 Guangdong Annuo Pharmaceuticals Company Details

11.7.2 Guangdong Annuo Pharmaceuticals Business Overview

11.7.3 Guangdong Annuo Pharmaceuticals Long-acting Melatonin Receptor Agonists Introduction

11.7.4 Guangdong Annuo Pharmaceuticals Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025)

11.7.5 Guangdong Annuo Pharmaceuticals Recent Development

11.8 Sichuan Kelun Pharmaceuticals

11.8.1 Sichuan Kelun Pharmaceuticals Company Details

11.8.2 Sichuan Kelun Pharmaceuticals Business Overview

11.8.3 Sichuan Kelun Pharmaceuticals Long-acting Melatonin Receptor Agonists Introduction

11.8.4 Sichuan Kelun Pharmaceuticals Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025)

11.8.5 Sichuan Kelun Pharmaceuticals Recent Development

11.9 Hangzhou Lingye Pharmaceutical Technology

11.9.1 Hangzhou Lingye Pharmaceutical Technology Company Details

11.9.2 Hangzhou Lingye Pharmaceutical Technology Business Overview

11.9.3 Hangzhou Lingye Pharmaceutical Technology Long-acting Melatonin Receptor Agonists Introduction

11.9.4 Hangzhou Lingye Pharmaceutical Technology Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025)

11.9.5 Hangzhou Lingye Pharmaceutical Technology Recent Development

11.10 Sichuan Guowei Pharmaceuticals

11.10.1 Sichuan Guowei Pharmaceuticals Company Details

11.10.2 Sichuan Guowei Pharmaceuticals Business Overview

11.10.3 Sichuan Guowei Pharmaceuticals Long-acting Melatonin Receptor Agonists Introduction

11.10.4 Sichuan Guowei Pharmaceuticals Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025)

11.10.5 Sichuan Guowei Pharmaceuticals Recent Development

11.11 Takeda

11.11.1 Takeda Company Details

11.11.2 Takeda Business Overview

11.11.3 Takeda Long-acting Melatonin Receptor Agonists Introduction

11.11.4 Takeda Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025)

11.11.5 Takeda Recent Development

11.12 Dr Reddy's Laboratories

11.12.1 Dr Reddy's Laboratories Company Details

11.12.2 Dr Reddy's Laboratories Business Overview

11.12.3 Dr Reddy's Laboratories Long-acting Melatonin Receptor Agonists Introduction

11.12.4 Dr Reddy's Laboratories Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025)

11.12.5 Dr Reddy's Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Vanda Pharmaceuticals

Servier Laboratories

Rovi Pharma

Novartis

Nectid Inc

Takeda

Dr. Reddy’s Laboratories

Jiangsu Hausen Pharmaceuticals

Guangdong Annuo Pharmaceuticals

Sichuan Kelun Pharmaceuticals

Hangzhou Lingye Pharmaceutical Technology

Sichuan Guowei Pharmaceuticals

List of Tables

Table 1. Global Long-acting Melatonin Receptor Agonists Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Ramelteon

Table 3. Key Players of Agomelatine

Table 4. Key Players of Other

Table 5. Global Long-acting Melatonin Receptor Agonists Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Long-acting Melatonin Receptor Agonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Long-acting Melatonin Receptor Agonists Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Long-acting Melatonin Receptor Agonists Market Share by Region (2020-2025)

Table 9. Global Long-acting Melatonin Receptor Agonists Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Long-acting Melatonin Receptor Agonists Market Share by Region (2026-2031)

Table 11. Long-acting Melatonin Receptor Agonists Market Trends

Table 12. Long-acting Melatonin Receptor Agonists Market Drivers

Table 13. Long-acting Melatonin Receptor Agonists Market Challenges

Table 14. Long-acting Melatonin Receptor Agonists Market Restraints

Table 15. Global Long-acting Melatonin Receptor Agonists Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Long-acting Melatonin Receptor Agonists Market Share by Players (2020-2025)

Table 17. Global Top Long-acting Melatonin Receptor Agonists Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Melatonin Receptor Agonists as of 2024)

Table 18. Ranking of Global Top Long-acting Melatonin Receptor Agonists Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Long-acting Melatonin Receptor Agonists Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Long-acting Melatonin Receptor Agonists, Headquarters and Area Served

Table 21. Global Key Players of Long-acting Melatonin Receptor Agonists, Product and Application

Table 22. Global Key Players of Long-acting Melatonin Receptor Agonists, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Long-acting Melatonin Receptor Agonists Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Type (2020-2025)

Table 26. Global Long-acting Melatonin Receptor Agonists Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Type (2026-2031)

Table 28. Global Long-acting Melatonin Receptor Agonists Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Application (2020-2025)

Table 30. Global Long-acting Melatonin Receptor Agonists Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Application (2026-2031)

Table 32. North America Long-acting Melatonin Receptor Agonists Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Long-acting Melatonin Receptor Agonists Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Long-acting Melatonin Receptor Agonists Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Long-acting Melatonin Receptor Agonists Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Long-acting Melatonin Receptor Agonists Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Long-acting Melatonin Receptor Agonists Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Long-acting Melatonin Receptor Agonists Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Country (2026-2031) & (US$ Million)

Table 47. Vanda Pharmaceuticals Company Details

Table 48. Vanda Pharmaceuticals Business Overview

Table 49. Vanda Pharmaceuticals Long-acting Melatonin Receptor Agonists Product

Table 50. Vanda Pharmaceuticals Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025) & (US$ Million)

Table 51. Vanda Pharmaceuticals Recent Development

Table 52. Servier Laboratories Company Details

Table 53. Servier Laboratories Business Overview

Table 54. Servier Laboratories Long-acting Melatonin Receptor Agonists Product

Table 55. Servier Laboratories Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025) & (US$ Million)

Table 56. Servier Laboratories Recent Development

Table 57. Rovi Pharma Company Details

Table 58. Rovi Pharma Business Overview

Table 59. Rovi Pharma Long-acting Melatonin Receptor Agonists Product

Table 60. Rovi Pharma Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025) & (US$ Million)

Table 61. Rovi Pharma Recent Development

Table 62. Novartis Company Details

Table 63. Novartis Business Overview

Table 64. Novartis Long-acting Melatonin Receptor Agonists Product

Table 65. Novartis Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025) & (US$ Million)

Table 66. Novartis Recent Development

Table 67. Nectid Inc Company Details

Table 68. Nectid Inc Business Overview

Table 69. Nectid Inc Long-acting Melatonin Receptor Agonists Product

Table 70. Nectid Inc Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025) & (US$ Million)

Table 71. Nectid Inc Recent Development

Table 72. Jiangsu Hausen Pharmaceuticals Company Details

Table 73. Jiangsu Hausen Pharmaceuticals Business Overview

Table 74. Jiangsu Hausen Pharmaceuticals Long-acting Melatonin Receptor Agonists Product

Table 75. Jiangsu Hausen Pharmaceuticals Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025) & (US$ Million)

Table 76. Jiangsu Hausen Pharmaceuticals Recent Development

Table 77. Guangdong Annuo Pharmaceuticals Company Details

Table 78. Guangdong Annuo Pharmaceuticals Business Overview

Table 79. Guangdong Annuo Pharmaceuticals Long-acting Melatonin Receptor Agonists Product

Table 80. Guangdong Annuo Pharmaceuticals Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025) & (US$ Million)

Table 81. Guangdong Annuo Pharmaceuticals Recent Development

Table 82. Sichuan Kelun Pharmaceuticals Company Details

Table 83. Sichuan Kelun Pharmaceuticals Business Overview

Table 84. Sichuan Kelun Pharmaceuticals Long-acting Melatonin Receptor Agonists Product

Table 85. Sichuan Kelun Pharmaceuticals Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025) & (US$ Million)

Table 86. Sichuan Kelun Pharmaceuticals Recent Development

Table 87. Hangzhou Lingye Pharmaceutical Technology Company Details

Table 88. Hangzhou Lingye Pharmaceutical Technology Business Overview

Table 89. Hangzhou Lingye Pharmaceutical Technology Long-acting Melatonin Receptor Agonists Product

Table 90. Hangzhou Lingye Pharmaceutical Technology Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025) & (US$ Million)

Table 91. Hangzhou Lingye Pharmaceutical Technology Recent Development

Table 92. Sichuan Guowei Pharmaceuticals Company Details

Table 93. Sichuan Guowei Pharmaceuticals Business Overview

Table 94. Sichuan Guowei Pharmaceuticals Long-acting Melatonin Receptor Agonists Product

Table 95. Sichuan Guowei Pharmaceuticals Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025) & (US$ Million)

Table 96. Sichuan Guowei Pharmaceuticals Recent Development

Table 97. Takeda Company Details

Table 98. Takeda Business Overview

Table 99. Takeda Long-acting Melatonin Receptor Agonists Product

Table 100. Takeda Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025) & (US$ Million)

Table 101. Takeda Recent Development

Table 102. Dr Reddy's Laboratories Company Details

Table 103. Dr Reddy's Laboratories Business Overview

Table 104. Dr Reddy's Laboratories Long-acting Melatonin Receptor Agonists Product

Table 105. Dr Reddy's Laboratories Revenue in Long-acting Melatonin Receptor Agonists Business (2020-2025) & (US$ Million)

Table 106. Dr Reddy's Laboratories Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Long-acting Melatonin Receptor Agonists Picture

Figure 2. Global Long-acting Melatonin Receptor Agonists Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Long-acting Melatonin Receptor Agonists Market Share by Type: 2024 VS 2031

Figure 4. Ramelteon Features

Figure 5. Agomelatine Features

Figure 6. Other Features

Figure 7. Global Long-acting Melatonin Receptor Agonists Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Long-acting Melatonin Receptor Agonists Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Other Case Studies

Figure 12. Long-acting Melatonin Receptor Agonists Report Years Considered

Figure 13. Global Long-acting Melatonin Receptor Agonists Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Long-acting Melatonin Receptor Agonists Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Long-acting Melatonin Receptor Agonists Market Share by Region: 2024 VS 2031

Figure 16. Global Long-acting Melatonin Receptor Agonists Market Share by Players in 2024

Figure 17. Global Long-acting Melatonin Receptor Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Long-acting Melatonin Receptor Agonists Revenue in 2024

Figure 19. North America Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Long-acting Melatonin Receptor Agonists Market Share by Country (2020-2031)

Figure 21. United States Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Long-acting Melatonin Receptor Agonists Market Share by Country (2020-2031)

Figure 25. Germany Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Share by Region (2020-2031)

Figure 33. China Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Long-acting Melatonin Receptor Agonists Market Share by Country (2020-2031)

Figure 41. Mexico Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Share by Country (2020-2031)

Figure 45. Turkey Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Long-acting Melatonin Receptor Agonists Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Vanda Pharmaceuticals Revenue Growth Rate in Long-acting Melatonin Receptor Agonists Business (2020-2025)

Figure 49. Servier Laboratories Revenue Growth Rate in Long-acting Melatonin Receptor Agonists Business (2020-2025)

Figure 50. Rovi Pharma Revenue Growth Rate in Long-acting Melatonin Receptor Agonists Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Long-acting Melatonin Receptor Agonists Business (2020-2025)

Figure 52. Nectid Inc Revenue Growth Rate in Long-acting Melatonin Receptor Agonists Business (2020-2025)

Figure 53. Jiangsu Hausen Pharmaceuticals Revenue Growth Rate in Long-acting Melatonin Receptor Agonists Business (2020-2025)

Figure 54. Guangdong Annuo Pharmaceuticals Revenue Growth Rate in Long-acting Melatonin Receptor Agonists Business (2020-2025)

Figure 55. Sichuan Kelun Pharmaceuticals Revenue Growth Rate in Long-acting Melatonin Receptor Agonists Business (2020-2025)

Figure 56. Hangzhou Lingye Pharmaceutical Technology Revenue Growth Rate in Long-acting Melatonin Receptor Agonists Business (2020-2025)

Figure 57. Sichuan Guowei Pharmaceuticals Revenue Growth Rate in Long-acting Melatonin Receptor Agonists Business (2020-2025)

Figure 58. Takeda Revenue Growth Rate in Long-acting Melatonin Receptor Agonists Business (2020-2025)

Figure 59. Dr Reddy's Laboratories Revenue Growth Rate in Long-acting Melatonin Receptor Agonists Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Agomelatine Market Research Report 2024

Global Tasimelteon Market Research Report 2025

Global Melanocortin Agonist Market Research Report 2024

Global Dopamine Receptor Agonists Market Research Report 2025

Global Novel Benzodiazepine Receptor Agonists Market Research Report 2025

Global GLP 1 Receptor Agonist Drugs Market Research Report 2024

Global Dopamine Receptor Agonists For PD Market Research Report 2025

Global Melatonin Market Research Report 2025

Melatonine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Melatonin Capsules Market Research Report 2024

Gamma aminobutyric Acid GABA Receptor Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global THR β Agonists Market Research Report 2024

Global GABAA Receptor Agonists Market Research Report 2025

Global Melatonin 5 Htp And Serotonin Market Research Report 2025

Global 5 HT Receptor Antagonist Market Research Report 2025

Global γ Aminobutyric Acid Receptor Agonists Market Research Report 2025

Opioid Receptor Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Grade Melatonin Products Market Research Report 2024

Global GLP 1 Receptor Antagonist Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions